Childhood Asthma Management Program: lessons learned

Area of Science:

• Pediatric Pulmonology
• Clinical Asthma Research
• Long-term Intervention Studies

Background:

• The National Heart, Lung, and Blood Institute Childhood Asthma Management Program (CAMP) is a landmark study.
• It is the largest and most comprehensive investigation of long-term anti-inflammatory therapy for mild to moderate childhood asthma.
• The study enrolled over 1000 children with persistent asthma.

Purpose of the Study:

• To review key findings from the CAMP study.
• To share lessons learned from conducting a decade-long research project in pediatric asthma.
• To evaluate the long-term impact of anti-inflammatory treatment on children's asthma management.

Main Methods:

• Longitudinal study design.
• Inclusion of over 1000 children with persistent asthma.
• Focus on anti-inflammatory interventions, specifically inhaled corticosteroids.

Main Results:

• Long-term inhaled corticosteroid (ICS) treatment demonstrated sustained improvement in asthma symptoms.
• Airway responsiveness remained improved with continued ICS use.
• A key finding was the absence of a continued effect of ICS on lung growth during the long-term follow-up period.

Conclusions:

• While inhaled corticosteroids effectively manage asthma symptoms and airway responsiveness in children long-term, their impact on lung growth may not be sustained.
• The CAMP study provides valuable insights into the complexities of managing childhood asthma over extended periods.
• Further research is needed to understand the long-term effects of asthma interventions on lung development.